mutations specified The point that, as spelled out under, CLL therapy is predicated on the presence or absence of these mutations. The present consensus is the fact, apart from clonal mutations, subclonal mutations which has a variant allelic frequency ranging from 5 to ten% (and therefore under the brink of detection by traditional molecular techn